| Application no. and date | 06755024.4 (espacenet) (Federated) (European Patent Register), 20060504 | | Patent/reg. no. and date | DK/EP 1877070, 20081231 | | Publication date | 20080116 | | Priority no. and date | EP 05009802, 20050505, US 680493 P, 20050513 | | EP pub. no. and date |
EP 1877070 20080116 | | Effective date | | | Applicant/owner | Antisense Pharma GmbH, Josef Engert Strasse 9
93053 Regensburg, DE | | Applicant ref. no. | PA 86112 | | Inventor | SCHLINGENSIEPEN, Karl-Hermann, Schubertstrasse 5
93093 Donaustauf, DE,
SCHLINGENSIEPEN, Reimar, Auf der Platte 4
93051 Regensburg, DE | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/7125 (2006.01) , A61P 25/00 (2006.01) , A61P 35/00 (2006.01) , A61P 37/06 (2006.01) | | Title | Terapeutisk anvendelse af TGF-beta2 antisense-oligonucleotider | | Int. application no. | EP2006062067 | | Int. publication no. | WO2006117400 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
